|Articles|June 21, 2023
Common approaches to bioanalysis of oligonucleotides
Author(s) Pyxant
The significance of oligonucleotides (OGNTs) in drug development is increasing rapidly, as they offer promising and life-changing treatments that can improve patients' lives. Within bioanalysis, there are five main approaches to consider, each of which has its advantages and disadvantages.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Trending on Pharmaceutical Technology
1
Drug Digest: Outsourcing Partnerships Fuel Global Biopharma Discovery and Scale-Up
2
FDA Grants Priority Review For Pfizer’s Marstacimab for Hemophilia A or B
3
The Role of Standards in Sustainability
4
Shaping the Future of Microbial Development: From Gene to GMP
5